益丰药房
(603939)
| 流通市值:317.28亿 | | | 总市值:317.28亿 |
| 流通股本:12.12亿 | | | 总股本:12.12亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 18,235,705,366.43 | 12,129,983,982.07 | 6,085,003,538.59 | 24,433,165,197.5 |
| 营业总成本 | 16,277,422,543.41 | 10,737,842,732.39 | 5,386,162,931.81 | 22,129,134,049.16 |
| 其他经营收益 | | | | |
| 营业利润 | 2,039,932,305.59 | 1,446,642,520.67 | 727,664,900.37 | 2,453,723,769.8 |
| 利润总额 | 2,025,752,740.7 | 1,441,769,394.05 | 723,639,787.14 | 2,456,394,852.41 |
| 净利润 | 1,521,301,252.75 | 1,069,067,642.08 | 546,085,134.16 | 1,831,025,556.6 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | 75,076,268.99 |
| 综合收益总额 | 1,521,301,252.75 | 1,069,067,642.08 | 546,085,134.16 | 1,906,101,825.59 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 16,168,984,806.14 | 15,548,141,073.62 | 16,388,210,229.75 | 16,825,997,154.25 |
| 非流动资产: | | | | |
| 非流动资产合计 | 10,186,946,243.35 | 10,281,052,358.61 | 10,447,144,268.21 | 10,625,926,894.33 |
| 资产总计 | 26,355,931,049.49 | 25,829,193,432.23 | 26,835,354,497.96 | 27,451,924,048.58 |
| 流动负债: | | | | |
| 流动负债合计 | 10,365,583,804.09 | 9,703,566,118.65 | 10,656,988,771.62 | 11,752,772,950.11 |
| 非流动负债: | | | | |
| 非流动负债合计 | 3,137,760,104.66 | 3,165,700,439.78 | 3,258,803,928.91 | 3,320,542,814.71 |
| 负债合计 | 13,503,343,908.75 | 12,869,266,558.43 | 13,915,792,700.53 | 15,073,315,764.82 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 12,020,202,267.78 | 12,117,509,052.36 | 12,133,848,482.5 | 11,634,287,444.84 |
| 股东权益合计 | 12,852,587,140.74 | 12,959,926,873.8 | 12,919,561,797.43 | 12,378,608,283.76 |
| 负债和股东权益合计 | 26,355,931,049.49 | 25,829,193,432.23 | 26,835,354,497.96 | 27,451,924,048.58 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 20,146,047,725.84 | 13,583,319,778.94 | 7,013,341,234.55 | 26,303,555,418.05 |
| 经营活动现金流出小计 | 17,361,295,104.02 | 12,129,760,144.27 | 5,956,969,996.44 | 22,945,107,403.64 |
| 经营活动产生的现金流量净额 | 2,784,752,621.82 | 1,453,559,634.67 | 1,056,371,238.11 | 3,358,448,014.41 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 19,014,181,684.14 | 11,106,020,077.87 | 5,121,166,287.98 | 24,251,873,963.89 |
| 投资活动现金流出小计 | 18,354,382,106.11 | 10,538,304,054.45 | 5,427,070,017.78 | 25,678,052,852.81 |
| 投资活动产生的现金流量净额 | 659,799,578.03 | 567,716,023.42 | -305,903,729.8 | -1,426,178,888.92 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | 1,762,800 |
| 筹资活动现金流出小计 | 1,993,042,180.51 | 1,158,536,808.44 | 328,357,053.98 | 2,481,561,351.78 |
| 筹资活动产生的现金流量净额 | -1,993,042,180.51 | -1,158,536,808.44 | -328,357,053.98 | -2,479,798,551.78 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 1,451,510,019.34 | 862,738,849.65 | 422,110,454.33 | -547,529,426.29 |
| 期末现金及现金等价物余额 | 3,064,778,463.57 | 2,476,007,293.88 | 2,035,378,898.56 | 1,613,268,444.23 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 862,738,849.65 | - | -547,529,426.29 |
最新报告期:2026-11-14| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东方证券 | 伍云飞,袁润璞 | 1.53 | 1.76 | 1.89 | 2026-11-14 |
| 华创证券 | 郑辰,高初蕾 | 1.60 | 1.83 | 2.05 | 2026-11-11 |
| 中信建投 | 沈兴熙,贺菊颖 | 1.54 | 1.78 | 2.06 | 2026-11-10 |
| 中金公司 | 张琎,李千翊 | 1.53 | 1.76 | -- | 2026-11-03 |
| 招商证券 | 方秋实,梁广楷,许菲菲 | 1.54 | 1.73 | 1.91 | 2026-11-03 |